Get the Stockscreener App
1.53
0.66%
0.0497
Edesa Biotech Inc stock is traded at $1.53, with a volume of 26,260.
It is up +0.66% in the last 24 hours and down -15.34% over the past month.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
See More
Previous Close:
$1.4803
Open:
$1.505
24h Volume:
26,260
Relative Volume:
0.09
Market Cap:
$12.58M
Revenue:
-
Net Income/Loss:
$-7.72M
P/E Ratio:
-0.5797
EPS:
-2.6394
Net Cash Flow:
$-6.25M
1W Performance:
-1.32%
1M Performance:
-15.34%
6M Performance:
-28.37%
1Y Performance:
-20.95%
1-Day Range:
$1.48
$1.55
1-Week Range:
$1.4101
$1.55
52-Week Range:
$1.275
$4.4899
Edesa Biotech Inc Stock (EDSA) Company Profile
Name
Edesa Biotech Inc
Sector
Industry
Phone
(905) 475-1234
Address
100 SPY COURT, MARKHAM, ON
Compare EDSA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EDSA
Edesa Biotech Inc
|
1.5091 | 12.34M | 0 | -7.72M | -6.25M | -2.6394 |
|
VRTX
Vertex Pharmaceuticals Inc
|
467.92 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
773.55 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
405.75 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
801.69 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
174.75 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Edesa Biotech Inc Stock (EDSA) Latest News
Edesa Biotech Inc. (EDSA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Market Recap: How robust is Invesco Bloomberg Analyst Rating Improvers stock financial positionMarket Performance Recap & Long-Term Safe Investment Plans - moha.gov.vn
What is the fair value of Edesa Biotech Inc. stock nowForecast Cut & Community Trade Idea Sharing - Улправда
Is Edesa Biotech Inc. stock supported by strong fundamentals2025 AllTime Highs & Daily Technical Stock Forecast Reports - Улправда
Will Edesa Biotech Inc. stock recover faster than peersBond Market & Stepwise Swing Trade Plans - DonanımHaber
Diluted earnings per share (diluted EPS) of Edesa Biotech, Inc. – BOATS:EDSA - TradingView — Track All Markets
Published on: 2025-12-18 16:05:47 - Улправда
Why analysts remain bullish on Edesa Biotech Inc. stockGap Down & Breakout Confirmation Alerts - Улправда
S P Trends: Is Edesa Biotech Inc. stock supported by strong fundamentals2025 Retail Activity & Low Risk High Win Rate Stock Picks - Улправда
Zacks Small Cap Comments on Edesa Biotech Q1 Earnings - Defense World
Zacks Small Cap Forecasts Edesa Biotech FY2028 Earnings - Defense World
EDSA: Gearing Up to Initiate Phase 2 Vitiligo Trial in Mid-2026 - Zacks Small Cap Research
Edesa Biotech advances dermatology and respiratory programs in fiscal 2025 - MSN
Edesa Biotech Advances Dermatology and Respiratory Programs in Fiscal 2025 - TipRanks
Edesa Biotech increases at-the-market offering limit to $2.26 million - Investing.com
[8-K] Edesa Biotech, Inc. Reports Material Event | EDSA SEC FilingForm 8-K - Stock Titan
[424B5] Edesa Biotech, Inc. Prospectus Supplement (Debt Securities) - Stock Titan
Edesa Biotech, Inc. SEC 10-K Report - TradingView — Track All Markets
Edesa Biotech, Inc. Reports Earnings Results for the Full Year Ended September 30, 2025 - marketscreener.com
Edesa Biotech (NASDAQ: EDSA) details fiscal 2025 results press release - Stock Titan
Edesa Biotech Reports Fiscal Year 2025 Results - The Manila Times
Edesa Biotech, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
How buybacks impact Edesa Biotech Inc. stock valueWeekly Stock Recap & Real-Time Volume Surge Alerts - Newser
Edesa Biotech (EDSA) to Release Earnings on Friday - Defense World
Will Edesa Biotech Inc. stock deliver consistent dividendsBond Market & Weekly High Potential Stock Alerts - Newser
Will Edesa Biotech Inc. stock deliver better than expected guidanceJuly 2025 Chart Watch & Daily Profit Maximizing Trade Tips - newser.com
What technical signals suggest for Edesa Biotech Inc. stock2025 Earnings Impact & Safe Capital Allocation Plans - newser.com
Will Edesa Biotech Inc. stock continue upward momentumJuly 2025 Review & Fast Gaining Stock Reports - newser.com
Edesa Biotech, Inc.Common Shares (NQ: EDSA - Markets Financial Content
Is Edesa Biotech Inc. stock affected by interest rate hikesJuly 2025 Gainers & Free Growth Oriented Trading Recommendations - newser.com
Best data tools to analyze Edesa Biotech Inc. stock2025 Fundamental Recap & Safe Swing Trade Setup Alerts - newser.com
Can Edesa Biotech Inc. stock sustain market leadership2025 Momentum Check & Risk Adjusted Swing Trade Ideas - newser.com
Will Edesa Biotech Inc. stock benefit from sector rotationMarket Rally & Scalable Portfolio Growth Methods - newser.com
Edesa Biotech, Inc. (EDSA) Presents at LSX Investival Showcase Europe 2025Slideshow - Seeking Alpha
Edesa Biotech Inc Stock (EDSA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.45%
0.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):